Press release
Opioid-Induced Constipation market size was US$ 2456.3 million and it is expected to reach US$ 3377 million by the end of 2026, with a CAGR of 4.6%
LOS ANGELES, United States: QY Research has recently published a research report titled, “Global Opioid-Induced Constipation Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Opioid-Induced Constipation market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Opioid-Induced Constipation market.
The report includes CAGR, market shares, sales, gross margin, value, volume, and other vital market figures that give an exact picture of the growth of the global Opioid-Induced Constipation market.
Top Companies/Manufacturers:
, Takeda Pharmaceuticals, Bayer, Sanofi, Mallinckrodt, Salix (Bausch Health), AstraZeneca, Progenics Pharmaceuticals, Purdue Pharm, Nektar Therapeutics, Daiichi Sankyo, Prestige, GSK, Shionogi
Market Segment by Product Type: Methylnaltrexone Bromide, Lubiprostone, Naloxegol, Others
Market Segment by Application: Hospital, Pharmacy
Get PDF Sample Copy of the Report @
https://www.qyresearch.com/sample-form/form/1944668/global-opioid-induced-constipation-market
For Customization in the Report Drop Your Query Here:
https://www.qyresearch.com/customize-request/form/1944668/global-opioid-induced-constipation-market
Buy Now:
https://www.qyresearch.com/settlement/pre/79589a440152d737764f19a15ad75ec9,0,1,global-opioid-induced-constipation-market
Competitive Landscape
Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Opioid-Induced Constipation market.
Key questions answered in the report:
What is the growth potential of the Opioid-Induced Constipation market?
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in the coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in the Opioid-Induced Constipation industry in the years to come?
What are the key challenges that the global Opioid-Induced Constipation market may face in the future?
Which are the leading companies in the global Opioid-Induced Constipation market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain hold in the global Opioid-Induced Constipation market
TOC
1 Study Coverage
1.1 Opioid-Induced Constipation Product Introduction
1.2 Market by Type
1.2.1 Global Opioid-Induced Constipation Market Size Growth Rate by Type
1.2.2 Methylnaltrexone Bromide
1.2.3 Lubiprostone
1.2.4 Naloxegol
1.2.5 Others
1.3 Market by Application
1.3.1 Global Opioid-Induced Constipation Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered 2 Executive Summary
2.1 Global Opioid-Induced Constipation Market Size Estimates and Forecasts
2.1.1 Global Opioid-Induced Constipation Revenue 2015-2026
2.1.2 Global Opioid-Induced Constipation Sales 2015-2026
2.2 Opioid-Induced Constipation Market Size by Region: 2020 Versus 2026
2.3 Opioid-Induced Constipation Sales by Region (2015-2026)
2.3.1 Global Opioid-Induced Constipation Sales by Region: 2015-2020
2.3.2 Global Opioid-Induced Constipation Sales Forecast by Region (2021-2026)
2.3.3 Global Opioid-Induced Constipation Sales Market Share by Region (2015-2026)
2.4 Opioid-Induced Constipation Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Opioid-Induced Constipation Revenue by Region: 2015-2020
2.4.2 Global Opioid-Induced Constipation Revenue Forecast by Region (2021-2026)
2.4.3 Global Opioid-Induced Constipation Revenue Market Share by Region (2015-2026) 3 Global Opioid-Induced Constipation by Manufacturers
3.1 Global Top Opioid-Induced Constipation Manufacturers by Sales
3.1.1 Global Opioid-Induced Constipation Sales by Manufacturer (2015-2020)
3.1.2 Global Opioid-Induced Constipation Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Opioid-Induced Constipation Manufacturers by Revenue
3.2.1 Global Opioid-Induced Constipation Revenue by Manufacturer (2015-2020)
3.2.2 Global Opioid-Induced Constipation Revenue Share by Manufacturer (2015-2020)
3.3 Global Opioid-Induced Constipation Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Opioid-Induced Constipation Manufacturers Covered: Ranking by Revenue
3.4.2 Global Opioid-Induced Constipation Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Opioid-Induced Constipation Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Opioid-Induced Constipation Manufacturing Base Distribution, Product Type
3.5.1 Opioid-Induced Constipation Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Opioid-Induced Constipation Product Type
3.5.3 Date of International Manufacturers Enter into Opioid-Induced Constipation Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Company Profiles
4.1 Takeda Pharmaceuticals
4.1.1 Takeda Pharmaceuticals Corporation Information
4.1.2 Takeda Pharmaceuticals Description, Business Overview
4.1.3 Takeda Pharmaceuticals Opioid-Induced Constipation Products Offered
4.1.4 Takeda Pharmaceuticals Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.1.5 Takeda Pharmaceuticals Opioid-Induced Constipation Revenue by Product
4.1.6 Takeda Pharmaceuticals Opioid-Induced Constipation Revenue by Application
4.1.7 Takeda Pharmaceuticals Opioid-Induced Constipation Revenue by Geographic Area
4.1.8 Takeda Pharmaceuticals Opioid-Induced Constipation Revenue by Sales Channel
4.1.9 Takeda Pharmaceuticals Recent Development
4.2 Bayer
4.2.1 Bayer Corporation Information
4.2.2 Bayer Description, Business Overview
4.2.3 Bayer Opioid-Induced Constipation Products Offered
4.2.4 Bayer Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.2.5 Bayer Opioid-Induced Constipation Revenue by Product
4.2.6 Bayer Opioid-Induced Constipation Revenue by Application
4.2.7 Bayer Opioid-Induced Constipation Revenue by Geographic Area
4.2.8 Bayer Opioid-Induced Constipation Revenue by Sales Channel
4.2.9 Bayer Recent Development
4.3 Sanofi
4.3.1 Sanofi Corporation Information
4.3.2 Sanofi Description, Business Overview
4.3.3 Sanofi Opioid-Induced Constipation Products Offered
4.3.4 Sanofi Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.3.5 Sanofi Opioid-Induced Constipation Revenue by Product
4.3.6 Sanofi Opioid-Induced Constipation Revenue by Application
4.3.7 Sanofi Opioid-Induced Constipation Revenue by Geographic Area
4.3.8 Sanofi Opioid-Induced Constipation Revenue by Sales Channel
4.3.9 Sanofi Recent Development
4.4 Mallinckrodt
4.4.1 Mallinckrodt Corporation Information
4.4.2 Mallinckrodt Description, Business Overview
4.4.3 Mallinckrodt Opioid-Induced Constipation Products Offered
4.4.4 Mallinckrodt Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Mallinckrodt Opioid-Induced Constipation Revenue by Product
4.4.6 Mallinckrodt Opioid-Induced Constipation Revenue by Application
4.4.7 Mallinckrodt Opioid-Induced Constipation Revenue by Geographic Area
4.4.8 Mallinckrodt Opioid-Induced Constipation Revenue by Sales Channel
4.4.9 Mallinckrodt Recent Development
4.5 Salix (Bausch Health)
4.5.1 Salix (Bausch Health) Corporation Information
4.5.2 Salix (Bausch Health) Description, Business Overview
4.5.3 Salix (Bausch Health) Opioid-Induced Constipation Products Offered
4.5.4 Salix (Bausch Health) Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Salix (Bausch Health) Opioid-Induced Constipation Revenue by Product
4.5.6 Salix (Bausch Health) Opioid-Induced Constipation Revenue by Application
4.5.7 Salix (Bausch Health) Opioid-Induced Constipation Revenue by Geographic Area
4.5.8 Salix (Bausch Health) Opioid-Induced Constipation Revenue by Sales Channel
4.5.9 Salix (Bausch Health) Recent Development
4.6 AstraZeneca
4.6.1 AstraZeneca Corporation Information
4.6.2 AstraZeneca Description, Business Overview
4.6.3 AstraZeneca Opioid-Induced Constipation Products Offered
4.6.4 AstraZeneca Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.6.5 AstraZeneca Opioid-Induced Constipation Revenue by Product
4.6.6 AstraZeneca Opioid-Induced Constipation Revenue by Application
4.6.7 AstraZeneca Opioid-Induced Constipation Revenue by Geographic Area
4.6.8 AstraZeneca Recent Development
4.7 Progenics Pharmaceuticals
4.7.1 Progenics Pharmaceuticals Corporation Information
4.7.2 Progenics Pharmaceuticals Description, Business Overview
4.7.3 Progenics Pharmaceuticals Opioid-Induced Constipation Products Offered
4.7.4 Progenics Pharmaceuticals Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.7.5 Progenics Pharmaceuticals Opioid-Induced Constipation Revenue by Product
4.7.6 Progenics Pharmaceuticals Opioid-Induced Constipation Revenue by Application
4.7.7 Progenics Pharmaceuticals Opioid-Induced Constipation Revenue by Geographic Area
4.7.8 Progenics Pharmaceuticals Recent Development
4.8 Purdue Pharm
4.8.1 Purdue Pharm Corporation Information
4.8.2 Purdue Pharm Description, Business Overview
4.8.3 Purdue Pharm Opioid-Induced Constipation Products Offered
4.8.4 Purdue Pharm Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.8.5 Purdue Pharm Opioid-Induced Constipation Revenue by Product
4.8.6 Purdue Pharm Opioid-Induced Constipation Revenue by Application
4.8.7 Purdue Pharm Opioid-Induced Constipation Revenue by Geographic Area
4.8.8 Purdue Pharm Recent Development
4.9 Nektar Therapeutics
4.9.1 Nektar Therapeutics Corporation Information
4.9.2 Nektar Therapeutics Description, Business Overview
4.9.3 Nektar Therapeutics Opioid-Induced Constipation Products Offered
4.9.4 Nektar Therapeutics Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.9.5 Nektar Therapeutics Opioid-Induced Constipation Revenue by Product
4.9.6 Nektar Therapeutics Opioid-Induced Constipation Revenue by Application
4.9.7 Nektar Therapeutics Opioid-Induced Constipation Revenue by Geographic Area
4.9.8 Nektar Therapeutics Recent Development
4.10 Daiichi Sankyo
4.10.1 Daiichi Sankyo Corporation Information
4.10.2 Daiichi Sankyo Description, Business Overview
4.10.3 Daiichi Sankyo Opioid-Induced Constipation Products Offered
4.10.4 Daiichi Sankyo Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.10.5 Daiichi Sankyo Opioid-Induced Constipation Revenue by Product
4.10.6 Daiichi Sankyo Opioid-Induced Constipation Revenue by Application
4.10.7 Daiichi Sankyo Opioid-Induced Constipation Revenue by Geographic Area
4.10.8 Daiichi Sankyo Recent Development
4.11 Prestige
4.11.1 Prestige Corporation Information
4.11.2 Prestige Description, Business Overview
4.11.3 Prestige Opioid-Induced Constipation Products Offered
4.11.4 Prestige Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.11.5 Prestige Opioid-Induced Constipation Revenue by Product
4.11.6 Prestige Opioid-Induced Constipation Revenue by Application
4.11.7 Prestige Opioid-Induced Constipation Revenue by Geographic Area
4.11.8 Prestige Recent Development
4.12 GSK
4.12.1 GSK Corporation Information
4.12.2 GSK Description, Business Overview
4.12.3 GSK Opioid-Induced Constipation Products Offered
4.12.4 GSK Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.12.5 GSK Opioid-Induced Constipation Revenue by Product
4.12.6 GSK Opioid-Induced Constipation Revenue by Application
4.12.7 GSK Opioid-Induced Constipation Revenue by Geographic Area
4.12.8 GSK Recent Development
4.13 Shionogi
4.13.1 Shionogi Corporation Information
4.13.2 Shionogi Description, Business Overview
4.13.3 Shionogi Opioid-Induced Constipation Products Offered
4.13.4 Shionogi Opioid-Induced Constipation Sales, Revenue and Gross Margin (2015-2020)
4.13.5 Shionogi Opioid-Induced Constipation Revenue by Product
4.13.6 Shionogi Opioid-Induced Constipation Revenue by Application
4.13.7 Shionogi Opioid-Induced Constipation Revenue by Geographic Area
4.13.8 Shionogi Recent Development 5 Breakdown Data by Type
5.1 Global Opioid-Induced Constipation Sales by Type (2015-2026)
5.1.1 Global Opioid-Induced Constipation Sales by Type (2015-2020)
5.1.2 Global Opioid-Induced Constipation Sales Forecast by Type (2021-2026)
5.1.3 Global Opioid-Induced Constipation Sales Market Share by Type (2015-2026)
5.2 Global Opioid-Induced Constipation Revenue Forecast by Type (2015-2026)
5.2.1 Global Opioid-Induced Constipation Revenue by Type (2015-2020)
5.2.2 Global Opioid-Induced Constipation Revenue Forecast by Type (2021-2026)
5.2.3 Global Opioid-Induced Constipation Revenue Market Share by Type (2015-2026)
5.3 Opioid-Induced Constipation Average Selling Price (ASP) by Type (2015-2026) 6 Breakdown Data by Application
6.1 Global Opioid-Induced Constipation Sales by Application (2015-2026)
6.1.1 Global Opioid-Induced Constipation Sales by Application (2015-2020)
6.1.2 Global Opioid-Induced Constipation Sales Forecast by Application (2021-2026)
6.1.3 Global Opioid-Induced Constipation Sales Market Share by Application (2015-2026)
6.2 Global Opioid-Induced Constipation Revenue Forecast by Application (2015-2026)
6.2.1 Global Opioid-Induced Constipation Revenue by Application (2015-2020)
6.2.2 Global Opioid-Induced Constipation Revenue Forecast by Application (2021-2026)
6.2.3 Global Opioid-Induced Constipation Revenue Market Share by Application (2015-2026)
6.3 Opioid-Induced Constipation Average Selling Price (ASP) by Application (2015-2026) 7 North America
7.1 North America Opioid-Induced Constipation Market Size YoY Growth 2015-2026
7.2 North America Opioid-Induced Constipation Market Facts & Figures by Country
7.2.1 North America Opioid-Induced Constipation Sales by Country (2015-2026)
7.2.2 North America Opioid-Induced Constipation Revenue by Country (2015-2026)
7.3 North America Opioid-Induced Constipation Sales by Type
7.4 North America Opioid-Induced Constipation Sales by Application 8 Asia-Pacific
8.1 Asia-Pacific Opioid-Induced Constipation Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Opioid-Induced Constipation Market Facts & Figures by Region
8.2.1 Asia-Pacific Opioid-Induced Constipation Sales by Region (2015-2026)
8.2.2 Asia-Pacific Opioid-Induced Constipation Revenue by Region (2015-2026)
8.3 Asia-Pacific Opioid-Induced Constipation Sales by Type
8.4 Asia-Pacific Opioid-Induced Constipation Sales by Application 9 Europe
9.1 Europe Opioid-Induced Constipation Market Size YoY Growth 2015-2026
9.2 Europe Opioid-Induced Constipation Market Facts & Figures by Country
9.2.1 Europe Opioid-Induced Constipation Sales by Country (2015-2026)
9.2.2 Europe Opioid-Induced Constipation Revenue by Country (2015-2026)
9.3 Europe Opioid-Induced Constipation Sales by Type
9.4 Europe Opioid-Induced Constipation Sales by Application 10 Latin America
10.1 Latin America Opioid-Induced Constipation Market Size YoY Growth 2015-2026
10.2 Latin America Opioid-Induced Constipation Market Facts & Figures by Country
10.2.1 Latin America Opioid-Induced Constipation Sales by Country (2015-2026)
10.2.2 Latin America Opioid-Induced Constipation Revenue by Country (2015-2026)
10.3 Latin America Opioid-Induced Constipation Sales by Type
10.4 Latin America Opioid-Induced Constipation Sales by Application 11 Middle East and Africa
11.1 Middle East and Africa Opioid-Induced Constipation Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Opioid-Induced Constipation Market Facts & Figures by Country
11.2.1 Middle East and Africa Opioid-Induced Constipation Sales by Country (2015-2026)
11.2.2 Middle East and Africa Opioid-Induced Constipation Revenue by Country (2015-2026)
11.3 Middle East and Africa Opioid-Induced Constipation Sales by Type
11.4 Middle East and Africa Opioid-Induced Constipation Sales by Application 12 Supply Chain and Sales Channel Analysis
12.1 Opioid-Induced Constipation Supply Chain Analysis
12.2 Opioid-Induced Constipation Key Raw Materials and Upstream Suppliers
12.3 Opioid-Induced Constipation Clients Analysis
12.4 Opioid-Induced Constipation Sales Channel and Sales Model Analysis
12.4.1 Opioid-Induced Constipation Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Opioid-Induced Constipation Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Opioid-Induced Constipation Distributors 13 Market Dynamics
13.1 Opioid-Induced Constipation Market Drivers
13.2 Opioid-Induced Constipation Market Opportunities
13.3 Opioid-Induced Constipation Market Challenges
13.4 Opioid-Induced Constipation Market Restraints
13.5 Porter’s Five Forces Analysis 14 Research Findings and Conclusion 15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Contact Us:-
QY Research, INC.
17890 Castleton,
Suite 218,
Los Angeles, CA – 91748
USA: +1 626 295 2442
Email:
enquiry@qyresearch.com
Web:
http://www.qyresearch.com
-
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Opioid-Induced Constipation market size was US$ 2456.3 million and it is expected to reach US$ 3377 million by the end of 2026, with a CAGR of 4.6% here
News-ID: 2148151 • Views: …
More Releases from QY Research
Global and U.S. Hydrogen Odorants Market Report, Published by QY Research.
Hydrogen Odorants are chemical additives introduced into hydrogen gas streams to impart a detectable smell for leak detection and safety monitoring, since pure hydrogen is colorless and odorless. Effective odorants must provide distinct olfactory signals at very low concentrations, while maintaining compatibility with fuel cells, pipelines, and storage systems. Common candidates include sulfur-free organic compounds, terpenes, and nitrogen-containing molecules, developed as alternatives to natural gas odorants to prevent catalyst poisoning…
Global and U.S. 3-point / 4-point Bend Fixtures Market Report, Published by QY R …
3-point and 4-point Bend Fixtures are mechanical test assemblies designed to evaluate the flexural strength, stiffness, and fracture behavior of materials under bending loads. In a 3-point setup, the specimen is supported at two points with a single load applied at the midpoint, while the 4-point configuration distributes the load between two points for a more uniform stress region. These fixtures are widely used for plastics, composites, ceramics, metals, and…
Global and U.S. High Speed Flatbed Scanners Market Report, Published by QY Resea …
High Speed Flatbed Scanners are digital imaging devices designed to capture high-resolution scans of documents, photos, and bound materials with rapid throughput compared to standard flatbed units. Featuring advanced CCD/CIS sensors, duplex scanning, and automatic image correction software, they are essential for businesses, government agencies, libraries, and archival institutions managing large volumes of physical records.
https://www.qyresearch.com/reports/4942701/high-speed-flatbed-scanners
The global High Speed Flatbed Scanners market reached USD 2.2 billion in 2024, growing at a…
Steel Floor Panels Market to Reach USD 17,565 Million by 2031 Top 20 Company Glo …
Steel floor panels cover a range of products used in commercial, industrial and data-center construction: profiled steel decking for composite slabs, galvanized or coated steel raised-access panels for server rooms and offices, and engineered steel mezzanine/industrial floor panels for warehouses and manufacturing plants. They are selected for strength-to-weight ratio, speed of installation, fire performance (when specified with appropriate infill), recyclability and long service life. Product differentiation is driven by profile…
More Releases for Constipation
Evolving Market Trends In The Opioid-Induced Constipation Treatment Industry: St …
The Opioid-Induced Constipation Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Opioid-Induced Constipation Treatment Market Size During the Forecast Period?
The opioid-induced constipation treatment market, valued at $1.78 billion in 2024, is projected to increase to $1.9 billion in 2025, growing…
Key Trends Shaping the Future Constipation Laxative Market From 2025-2034: Innov …
How Are the key drivers contributing to the expansion of the constipation laxative market?
The rising prevalence of constipation is expected to boost the growth of the constipation laxative market. Constipation, characterized by infrequent or difficult bowel movements, is becoming more common due to changes in diet, sedentary lifestyles, inadequate fluid intake, and medical conditions. Constipation laxatives help relieve this condition by stimulating bowel movements or softening stools. A 2024 survey…
Leading Element Driving Change in the Constipation Laxative Market in 2025: Incr …
What Is the Estimated Market Size and Growth Rate for the Constipation Laxative Market?
The market for constipation laxatives has seen substantial expansion in the past few years. It is projected to further expand from $7 billion in 2024 to $7.44 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%. Factors contributing to this growth during the historical period include an increase in the elderly population, sedentary lifestyles,…
[Latest] Constipation Treatment Market : An Overview
The ""Constipation Treatment Market"" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023.
Growing Demand and Growth Potential in the Global Constipation Treatment Market, 2024-2031
Verified Market Research's most recent report, ""Constipation Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030,"" provides an in-depth…
How to Improve Constipation - Cassia Fistula Extract
Cassia Fistula Extract is a natural plant ingredient extracted from the friut of the Cassia Fistula tree and is widely used in traditional Chinese medicine and modern medicine.
Here are some common applications of Cassia Fistula Extract [https://www.ie-extract.com/cassia-fistula-extract-cassia-fistula-extract-treatment-of-constipation-product/]:
Promotes bowel movement and relieves constipation: Cassia Fistula Extract is believed to promote bowel movement and relieve constipation. Research shows that its active ingredients can stimulate intestinal motility, increase bowel movement frequency, and improve…
Opioid Induced Constipation Treatment Market
Opioids are medications that work on opioid receptors in order to generate morphine-like effects. These are mainly used therapeutically to relieve pain and are often abused by individuals addicted to them. Opioids comprises opiates, a conventional name that points to drugs that are derivatives of opium, including morphine. Constipation means bowel actions that are sporadic or hard to go by. The fecal matter is often dry and hard. Some of…
